All Stories

  1. Person-Centered Social Determinants and Neighborhood-Level Deprivation Associated With Disability in Hispanic People With Multiple Sclerosis
  2. Building a Digital Health Research Platform to Enable Recruitment, Enrollment, Data Collection, and Follow-Up for a Highly Diverse Longitudinal US Cohort of 1 Million People in the All of Us Research Program: Design and Implementation Study
  3. Multiple sclerosis in Colombia: A review of the literature
  4. Patients’ views on HCC biospecimen research: Understanding the role of race and culture through interviews
  5. Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population
  6. Heritability Estimation of Multiple Sclerosis Related Plasma Protein Levels in Sardinian Families with Immunochip Genotyping Data
  7. A genome-wide mutational constraint map quantified from variation in 76,156 human genomes
  8. Risk Factors Associated With Mortality and Neurologic Disability After Intracerebral Hemorrhage in a Racially and Ethnically Diverse Cohort
  9. Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans
  10. Genome sequencing reveals novel noncoding variants in PLA2G6 and LMNB1 causing progressive neurologic disease
  11. Functional analysis of a novel de novo variant in PPP5C associated with microcephaly, seizures, and developmental delay
  12. Loss of IRF2BPL impairs neuronal maintenance through excess Wnt signaling
  13. Plasma Protein Levels Analysis in Multiple Sclerosis Sardinian Families Identified C9 and CYP24A1 as Candidate Biomarkers
  14. Bilateral choanal stenosis in auriculocondylar syndrome caused by a PLCB4 variant
  15. The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder
  16. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids
  17. Homozygosity Haplotype and Whole-Exome Sequencing Analysis to Identify Potentially Functional Rare Variants Involved in Multiple Sclerosis among Sardinian Families
  18. Variable clinical severity in TANGO2 deficiency: Case series and literature review
  19. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations
  20. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11
  21. One is the loneliest number: genotypic matchmaking using the electronic health record
  22. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations
  23. Ethnic and Racial Variation in Intracerebral Hemorrhage Risk Factors and Risk Factor Burden
  24. Genetic counselor roles in the undiagnosed diseases network research study: Clinical care, collaboration, and curation
  25. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain
  26. Hypertension prevalence in the All of Us Research Program among groups traditionally underrepresented in medical research
  27. Clinical application of a scale to assess genomic healthcare empowerment (GEmS): Process and illustrative case examples
  28. “Doctors can read about it, they can know about it, but they've never lived with it”: How parents use social media throughout the diagnostic odyssey
  29. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases
  30. PPP3CA truncating variants clustered in the regulatory domain cause early‐onset refractory epilepsy
  31. TSPEAR variants are primarily associated with ectodermal dysplasia and tooth agenesis but not hearing loss: A novel cohort study
  32. Rare disease patient matchmaking: development and outcomes of an internet case-finding strategy in the Undiagnosed Diseases Network
  33. Progressive cerebellar atrophy in a patient with complex II and III deficiency and a novel deleterious variant in SDHA: A Counseling Conundrum
  34. Detection of a mosaic CDKL5 deletion and inversion by optical genome mapping ends an exhaustive diagnostic odyssey
  35. A novel de novo intronic variant in ITPR1 causes Gillespie syndrome
  36. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy
  37. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids
  38. Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease
  39. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science
  40. Effectiveness of film as a health communication tool to improve perceptions and attitudes in multiple sclerosis
  41. DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature
  42. Family genetic result communication in rare and undiagnosed disease communities: Understanding the practice
  43. Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans
  44. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder
  45. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
  46. Combining Imaging and Genetics to Predict Recurrence of Anticoagulation-Associated Intracerebral Hemorrhage
  47. Investigating the Causal Effect of Brain Expression of CCL2, NFKB1, MAPK14, TNFRSF1A, CXCL10 Genes on Multiple Sclerosis: A Two-Sample Mendelian Randomization Approach
  48. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation
  49. Understanding Participation in Genetic Research Among Patients With Multiple Sclerosis: The Influences of Ethnicity, Gender, Education, and Age
  50. Race and ethnicity on MS presentation and disease course
  51. A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System
  52. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
  53. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling
  54. Publisher Correction: Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein
  55. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein
  56. Fine-Mapping Array Design for Multi-Ethnic Studies of Multiple Sclerosis
  57. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy
  58. VarSight: prioritizing clinically reported variants with binary classification algorithms
  59. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects
  60. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
  61. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia
  62. The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States
  63. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia
  64. Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis
  65. The Puerto Rico Alzheimer Disease Initiative (PRADI): A Multisource Ascertainment Approach
  66. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification
  67. A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis
  68. Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity
  69. Determinants of Poor Outcome after Intracerebral Hemorrhage: Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) Study
  70. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations
  71. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk
  72. Native ancestry is associated with optic neuritis and age of onset in hispanics with multiple sclerosis
  73. Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease
  74. Enrichment of rare protein truncating variants in amyotrophic lateral sclerosis patients
  75. Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report
  76. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
  77. Investigating multiple sclerosis genetic susceptibility on the founder population of east-central Sardinia via association and linkage analysis of immune-related loci
  78. MS in self-identified Hispanic/Latino individuals living in the US
  79. Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba
  80. Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis
  81. Genetic Characterization and Influence on Inflammatory Bowel Disease Expression in a Diverse Hispanic South Florida Cohort
  82. The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis
  83. A childhood acute lymphoblastic leukemia genome-wide association study identifies novel sex-specific risk variants
  84. NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk
  85. Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency
  86. European multiple sclerosis risk variants in the south Asian population
  87. A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GMCSF
  88. Power estimation for non-standardized multisite studies
  89. GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis
  90. A catalog of HLA region SNPs with functional annotations, disease associations and correlations with HLA types
  91. Class II HLA interactions modulate genetic risk for multiple sclerosis
  92. Mutations inRIT1cause Noonan syndrome - additional functional evidence and expanding the clinical phenotype
  93. Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia
  94. 942 Racial/Ethnic Groupings Influence Methylation Signatures of Colorectal Cancers
  95. An ImmunoChip study of multiple sclerosis risk in African Americans
  96. Clinical Expression of Multiple Sclerosis in Hispanic Whites of Primarily Caribbean Ancestry
  97. Abstract B45: Microsatellite instability among disenfranchised minority colorectal cancer patients
  98. JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants
  99. Meta-analysis of Genome-wide Association Studies Identifies 1q22 as a Susceptibility Locus for Intracerebral Hemorrhage
  100. Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids
  101. Reconstructing the Population Genetic History of the Caribbean
  102. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
  103. Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients
  104. A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
  105. Su1772 Do Hispanic Patients With a High Genetic Risk Load Develop IBD At a Younger Age?
  106. Phenotypic Manifestations of Inflammatory Bowel Disease Differ Between Hispanics and Non-Hispanic Whites: Results of a Large Cohort Study
  107. Copy number variation in pediatric multiple sclerosis
  108. Evaluating Mitochondrial DNA Variation in Autism Spectrum Disorders
  109. Genome-Wide Association and Linkage Study in the Amish Detects a Novel Candidate Late-Onset Alzheimer Disease Gene
  110. Genetics in Diagnosing and Managing Inflammatory Bowel Disease
  111. Mitochondrial Haplogroup X is associated with successful aging in the Amish
  112. Genome-wide study for Alzheimer’s disease in the Amish
  113. A Genome-Wide Linkage Screen in the Amish with Parkinson Disease Points to Chromosome 6
  114. A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01
  115. Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility
  116. Genome-wide association study for dementia in the midwestern US Amish
  117. A Genome-wide Association Study of Autism Reveals a Common Novel Risk Locus at 5p14.1
  118. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
  119. The expanding genetic overlap between multiple sclerosis and type I diabetes
  120. P3-225: Whole-genome SNP linkage screen for dementia in the midwestern U.S. Amish
  121. Interleukin 7 receptor α chain (IL7R) shows allelic and functional association with multiple sclerosis
  122. SNPs in Multi-Species Conserved Sequences (MCS) as useful markers in association studies: a practical approach
  123. P1-287
  124. Lack of Association Between Autism andSLC25A12
  125. A genome-wide linkage analysis of dementia in the Amish
  126. Allelic Heterogeneity at the Serotonin Transporter Locus (SLC6A4) Confers Susceptibility to Autism and Rigid-Compulsive Behaviors
  127. A linkage disequilibrium map of the 1-Mb 15q12 GABAAreceptor subunit cluster and association to autism
  128. Dense linkage disequilibrium mapping in the 15q11–q13 maternal expression domain yields evidence for association in autism